切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2010, Vol. 04 ›› Issue (01) : 7 -9. doi: 10.3760/cma.j.issn.1674-0793.2010.01.103

所属专题: 文献

专家论坛

浅析肝细胞癌合并胆管癌栓诊疗难点
谭蔚锋1, 姜小清1   
  1. 1. 200438 上海,第二军医大学附属东方肝胆外科医院胆道一科
  • 收稿日期:2009-08-25 出版日期:2010-02-01

Analysis of difficulties in treatment of hepatocellular carcinoma with bile duct tumor thrombi

Wei-feng TAN1, Xiao-qing JIANG1   

  • Received:2009-08-25 Published:2010-02-01
引用本文:

谭蔚锋, 姜小清. 浅析肝细胞癌合并胆管癌栓诊疗难点[J]. 中华普通外科学文献(电子版), 2010, 04(01): 7-9.

Wei-feng TAN, Xiao-qing JIANG. Analysis of difficulties in treatment of hepatocellular carcinoma with bile duct tumor thrombi[J]. Chinese Archives of General Surgery(Electronic Edition), 2010, 04(01): 7-9.

1
Chen MF, Jan YY, Jeng LB, et al. Obstructive jaundice secondary to ruptured hepatocellular carcinoma into bile duct. Surgical experiences of 20 cases. Cancer, 1994, 73(5): 1335-1340.
2
Ikenaga N, Chijiiwa K, Otani K, et al. Clinicopathologic characteristics of hepatocellular carcinoma with bile duct invasion. J Gastrointest Surg, 2008, 13(3): 492-497.
3
Lau W, Leung K, Leung TW, et al. A logical approach to hepatocellular carcinoma presenting with jaundice. Ann Surg, 1997, 225(3): 281-285.
4
Satoh S, Ikai I, Honda G, et al. Clinicopathologic evaluation of hepatocellar carcinoma with bile duct thromb. Surgery, 2000, 128(5): 779-783.
5
Yeh CN, Jan YY, Lee WC, et al. Hepatic resection for hepatocellular carcinoma with obstructive jaundice due to biliary tumor thrombi. World J Surg, 2004, 28(5): 471-475.
6
Ueda M, Takeuchi T, Takayasu T, et al. Classification and surgical treatment of hepatocellular carcinoma (HCC) with bile duct thrombi. Hepatogastroenterology. 1994, 41(4): 349-354.
7
Lin TY, Chen KM, Chen YR, et al. Icteric type hepatoma. Med Chir Dig, 1975, 4(5-6): 267-270.
8
Peng BG, Liang LJ, Li SQ, et al. Surgical treatment of hepatocellular carcinoma with bile duct tumor thrombi. World J Gastroenterol, 2005, 11(25): 3966-3969.
9
王建伟, 马振峰, 刘颖斌, 等. 胆管癌栓致梗阻性黄疸的外科治疗分析. 中华医学杂志, 2006, 86(30): 2146-2148.
10
Lee KW, Park JW, Park JB, et al. Liver transplantation for hepatocellular carcinoma with bile duct thrombi. Transplant Proc, 2006, 38(7): 2093-2094.
11
谭蔚锋, 罗祥基, 张柏和, 等. 原发性肝癌合并胆管癌栓不同疗法的效果比较. 中国普通外科杂志, 2008, 17(10): 1033-1036.
12
Kojiro M, Kawabata K, Kawano Y, et al. Hepatocellular carcinoma presenting as intrabile duct tumor growth: a clinicopathologic study of 24 cases. Cancer, 1982, 49(10): 2144-2147.
13
吴孟超. 原发性肝癌的诊断和治疗进展. 中国医学科学院学报, 2008, 30(4): 363-365.
14
Shiomi M, Junichi K, Nagino M, et al. Hepatocellular carcinoma with biliary tumor thrombi: aggressive operative approach after appropriate preoperative management. Surgery, 2001, 129(2): 692-698.
15
Liu Q, Chen J, Li H, et al. Hepatocellular carcinoma with bile duct tumor thrombi: correlation of magnetic resonance imaging features to histopathologic manifestations. Eur J Radiol, 2009 Jun 8.
16
Gabata T, Terayama N, Kobayashi S, et al. MR imaging of hepatocellular carcinomas with biliary tumor thrombi. Abdom Imaging, 2007, 32(4): 470-474.
17
Huang JF, Chen SC, Wang LY, et al. Diagnosis of icteric-type hepatocellular carcinoma by fine needle aspiration: a case report. Acta Cytol, 2006, 50(5): 531-533.
18
丁磊, 陈孝平. 肝癌合并胆道癌栓. 解剖与临床, 2003, 8(3): 185-186.
19
曹杰, 罗时, 敏王辉, 等. 肝细胞癌合并胆管癌栓患者术中癌栓的处理. 中国医师进修杂志, 2006, 29(11): 22-24.
20
Narita R, Oto T, Mimura Y, et al. Biliary obstruction caused by intrabiliary transplantation from hepatocellular carcinoma. J Gastroenterol, 2002, 37(1): 55-58.
21
Lin SY, Pan HW, Liu SH, et al. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma. Clin Cancer Res, 2008, 14(15): 4814-4820.
22
Lee DC, Kang YK, Kim WH, et al. Functional and clinical evidence for NDRG2 N-myc downstream regulated gene 2 as a candidate suppressor of liver cancer metastasis. Cancer Res, 2008, 68(11): 4210-4220.
23
Fukase K, Ohtsuka H, Onogawa T, et al. Bile acids repress E-cadherin through the induction of Snail and increase cancer invasiveness in human hepatobiliary carcinoma. Cancer Sci, 2008, 99(9): 1785-1792.
24
Endo K, Ueda T, Ueyama J, et al. Immunoreactive E-cadherin,alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival. Hum Pathol, 2000, 31(5): 558-565.
No related articles found!
阅读次数
全文


摘要